GOSS (Gossamer Bio, Inc.) Short-Term Debt to Capital
Gossamer Bio, Inc. (GOSS) specializes in the therapy of inflammatory processes and immune system failures, leveraging a robust scientific foundation. The price trajectory shown below corresponds to the 0.00 indicator. Gossamer Bio, Inc. (GOSS) is implementing AI and robotics to accelerate the synthesis of new drugs. The business is currently in the testing phase and remains financially dependent on capital investments, as commercial sales have not yet launched.
Analytical breakdowns for Gossamer Bio, Inc.
- stock quotes and analyst forecast:
- business market valuation indicators:
- book capitalization information:
- company liabilities and liquidity data:
Fundamental valuation:Gossamer Corp
Investors utilize leverage multiples to verify an issuer's financial stability and assess bankruptcy risks. By analyzing the short-term debt-to-equity chart, one can determine the proportion of current liabilities within the asset structure of Gossamer Bio, Inc. (GOSS), which is critical for maintaining liquidity while conducting costly clinical trials of seralutinib amidst intense patent competition.
Main competitors
Short-Term Debt to Capital ARGX|BNTX (BioNTech Pharma) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital ABVX (Abivax Pharma)|Short-Term Debt to Capital admabiologics.com ADMA|PTGX - Short-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital IMVT (Immunovant Inc)|Kiniksa Pharmaceuticals Ltd (KNSA) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio Grifols Biemat|ADPT (Adaptive Biotechnologies) - Short-Term Debt to Capital|Short-Term Debt to Capital celldex.com|Short-Term Debt to Equity Ratio AUPH (Aurinia Pharmaceuticals Inc.)|BCRX (BioCryst Pharmaceuticals, Inc.) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital VERA (Vera Pharma)|Short-Term Debt to Capital Coefficient Dianthus Corp (DNTH)|PHVS - Short-Term Debt to Equity|AbCellera Biologics Inc (ABCL) - Short-Term Debt to Equity Ratio|Tourmaline Bio (TRML) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio Precigen Inc|Short-Term Debt to Equity Ratio PHAR|Short-Term Debt to Capital Nektar Corp|Short-Term Debt to Equity Upstream Bio Inc (UPB)|zenasbio.com - Short-Term Debt to Capital Ratio|Short-Term Debt to Capital IMNM (Immunome)|KalVista Pharma (KALV) - Current Liabilities to Capital|Septerna Corp - Short-Term Debt to Capital|Short-Term Indebtedness to Equity Pieris Corp (PVLA)|Savara Inc. (SVRA) - Short-Term Debt to Equity|Current Liabilities to Capital rigel.com (RIGL)|Short-Term Debt to Equity AnaptysBio|Astria Therapeutics Inc (ATXS) - Short-Term Debt to Capital Coefficient|Short-Term Debt to Equity enGene Bio (ENGN)|Short-Term Debt to Capital Coefficient rapt.com|Short-Term Debt to Capital JBIO (Aerovate Therapeutics)|Short-Term Debt to Capital aclaristx.com ACRS|KYTX - Short-Term Debt to Equity|Tiziana Life Sciences Ltd. (TLSA) - Short-Term Debt to Equity Ratio|CABA: Short-Term Debt to Capital|Current Liabilities to Capital Ventyx Biosciences, Inc (VTYX)|Short-Term Debt to Equity Theratechnologies Inc.|AVTX: Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity Ratio ELDN (Eledon Pharmaceuticals, Inc.)|AGEN (Agenus, Inc.) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital CLYM (Climb Bio, Inc.)|zurabio.com - Short-Term Debt to Equity|aTyr Pharma, Inc. - Short-Term Debt to Capital|Short-Term Debt to Capital Coefficient Adagene ADAG|ikenaoncology.com (IMA) - Short-Term Debt to Equity|Current Liabilities to Capital Shattuck Labs (STTK)|Short-Term Debt to Equity Ratio EQ|CNTB: Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital IMUX|Short-Term Debt to Capital Coefficient atarabio.com|Short-Term Debt to Equity InflaRx IFRX|XFOR: Short-Term Debt to Capital Ratio|Adicet - Short-Term Debt to Capital|Celularity Inc. (CELU) - Short-Term Debt to Equity Ratio|INMB (INmune Bio, Inc.) - Short-Term Debt to Equity Ratio|BRNS - Short-Term Debt to Capital Coefficient|KZR (Kezar Life Sciences, Inc.) - Short-Term Debt to Capital|SABS - Short-Term Indebtedness to Equity|Short-Term Debt to Equity Akari Therapeutics plc (AKTX)|ENLV - Current Liabilities to Capital|Short-Term Debt to Equity Q32 Bio QTTB|Short-Term Debt to Capital Coefficient geovax.com (GOVX)|EDSA - Short-Term Debt to Equity|Short-Term Debt to Capital Coefficient iBio Inc IBIO|carismatx.com (CARM) - Short-Term Debt to Equity|Current Liabilities to Equity XTLB (XTL Bio)|BOLT (Bolt Biotherapeutics Inc.) - Short-Term Debt to Capital|HCWB: Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital APVO|Short-Term Debt to Capital aimimmuno.com (AIM)|Short-Term Debt to Equity Aditxt, Inc. ADTX|Ratio of Short-Term Indebtedness to Capital GRI|XRTX - Short-Term Debt to Equity|reshapelifesciences.com (HIND) - Short-Term Debt to Equity Ratio|REVB: Short-Term Debt to Capital|Indaptus Therapeutics Inc (INDP) - Short-Term Debt to Capital|Short-Term Debt to Equity Ratio SCNI|CALI: Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital AFMD|Short-Term Debt to Capital Coefficient allakos.com|Short-Term Debt to Equity HOOKIPA Pharma HOOK|IGMS - Short-Term Debt to Equity Ratio|ITOS - Short-Term Debt to Equity|Ocean Biomedical Corp (OCEA) - Short-Term Debt to Equity Ratio|TCBP (TC Biopharm) - Short-Term Debt to Equity Ratio|thirdharmonicbio.com (THRD) - Short-Term Debt to Capital